{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:02:41Z","timestamp":1774465361299,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871197"],"award-info":[{"award-number":["31871197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H260003"],"award-info":[{"award-number":["LY21H260003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bcp.2024.116309","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:10:28Z","timestamp":1716390628000},"page":"116309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pregnane\u00a0X\u00a0receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F2\u03b1 (PGF2\u03b1) levels"],"prefix":"10.1016","volume":"225","author":[{"given":"Tong","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-Ying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Biao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5301-6119","authenticated-orcid":false,"given":"Shu-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116309_b0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2024.116309_b0010","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2024.116309_b0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/me.2005-0205","article-title":"Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells","volume":"20","author":"Gong","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116309_b0020","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2024.116309_b0025","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1074\/jbc.M113.494575","article-title":"Role of pregnane X receptor in obesity and glucose homeostasis in male mice","volume":"289","author":"Spruiell","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116309_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114698","article-title":"Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature","volume":"193","author":"Kim","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116309_b0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcp.2017.07.019","article-title":"Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression","volume":"142","author":"Zhao","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116309_b0040","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116309_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfab023","article-title":"Targeting xenobiotic nuclear receptors PXR and CAR to prevent cobicistat hepatotoxicity","volume":"181","author":"Shehu","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164087","article-title":"Role of PXR in hepatic cancer: its influences on liver detoxification capacity and cancer progression","volume":"11","author":"Kotiya","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116309_b0055","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/dmd.121.000481","article-title":"Distinct roles of the sister nuclear receptors PXR and CAR in liver cancer development","volume":"50","author":"Yoshinari","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116309_b0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/ard.60.6.627","article-title":"Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases","volume":"60","author":"Basu","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2024.116309_b0065","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/nm.2066","article-title":"Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta","volume":"15","author":"Oga","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116309_b0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.37767","article-title":"Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2alpha) synthesis through adipose triglyceride lipase\/calcium-independent phospholipase A(2)","volume":"65","author":"Kanno","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2024.116309_b0075","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/j.1476-5381.2009.00464.x","article-title":"Cyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colon","volume":"158","author":"Collins","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116309_b0080","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ijc.22755","article-title":"Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells","volume":"121","author":"Qualtrough","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2024.116309_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061487","article-title":"The role of prostaglandins in different types of cancer","volume":"10","author":"Jara-Gutierrez","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2024.116309_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mce.2015.07.008","article-title":"11beta-Prostaglandin F2alpha, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer","volume":"413","author":"Yoda","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116309_b0095","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1159\/000509671","article-title":"Evaluation of the diagnostic and predicative values of 8-iso-prostaglandin F2alpha as a biomarker of breast cancer","volume":"43","author":"Nour Eldin","year":"2020","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.bcp.2024.116309_b0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-5793(99)01551-3","article-title":"cDNA cloning, expression and characterization of human prostaglandin F synthase","volume":"462","author":"Suzuki-Yamamoto","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2024.116309_b0105","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1158\/0008-5472.CAN-06-1448","article-title":"17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer","volume":"66","author":"Jansson","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116309_b0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00795-007-0365-8","article-title":"In situ production of sex steroids in human breast carcinoma","volume":"40","author":"Suzuki","year":"2007","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.bcp.2024.116309_b0115","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-12-1335","article-title":"Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors","volume":"72","author":"Mitsiades","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116309_b0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2024.116309_b0125","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/cas.12700","article-title":"Differential reactivation of fetal\/neonatal genes in mouse liver tumors induced in cirrhotic and non-cirrhotic conditions","volume":"106","author":"Chen","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bcp.2024.116309_b0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1349-7006.2011.02143.x","article-title":"Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer","volume":"103","author":"Fujimura","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2014.01.026","article-title":"Activated pregnane X receptor inhibits cervical cancer cell proliferation and tumorigenicity by inducing G2\/M cell-cycle arrest","volume":"347","author":"Niu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2024.116309_b0145","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/sj.bjc.6605677","article-title":"Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells","volume":"102","author":"Ouyang","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2024.116309_b0150","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00204-020-02955-4","article-title":"The influence of the long-term chemical activation of the nuclear receptor pregnane X receptor (PXR) on liver carcinogenesis in mice","volume":"95","author":"Shizu","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2024.116309_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/carcin\/7.2.215","article-title":"Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL\/6NCr, C3H\/HeNCrMTV- and DBA\/2NCr mice","volume":"7","author":"Diwan","year":"1986","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2024.116309_b0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0300-483X(03)00077-5","article-title":"Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F(2 alpha)","volume":"188","author":"Wolfle","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2024.116309_b0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.prostaglandins.2018.06.003","article-title":"The prostanoid pathway contains potential prognostic markers for glioblastoma","volume":"137","author":"Panagopoulos","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bcp.2024.116309_b0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mce.2005.12.009","article-title":"Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors","volume":"248","author":"Penning","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116309_b0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2008.10.024","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase\/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs","volume":"178","author":"Byrns","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2024.116309_b0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jsbmb.2009.12.009","article-title":"Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer","volume":"118","author":"Byrns","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116309_b0185","first-page":"906","article-title":"Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer","volume":"63","author":"Gupta","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116309_b0190","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/0008-5472.CAN-05-4063","article-title":"Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer","volume":"66","author":"Daikoku","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2024.116309_b0195","first-page":"245","article-title":"The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells","volume":"17","author":"Lampiasi","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2024.116309_b0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00000441-199203000-00004","article-title":"Alpha-fetoprotein levels in normal adults","volume":"303","author":"Ball","year":"1992","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0205","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ijc.25373","article-title":"Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2024.116309_b0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0024-3205(98)00529-3","article-title":"Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro","volume":"64","author":"Wang","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2024.116309_b0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bcp.2024.116309_b0225","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.7150\/ijbs.76924","article-title":"Hepatic FGF21: its emerging role in inter-organ crosstalk and cancers","volume":"18","author":"Sui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2024.116309_b0230","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/liv.15100","article-title":"High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study","volume":"42","author":"Liu","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2024.116309_b0235","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","article-title":"Inflammation: the incubator of the tumor microenvironment","volume":"8","author":"Denk","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bcp.2024.116309_b0240","first-page":"13","article-title":"Cytokines and hepatocellular carcinoma: biomarkers of a deadly embrace","author":"Pocino","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bcp.2024.116309_b0245","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1111\/bph.15934","article-title":"Constitutive androstane receptor (CAR) mediates pyrene-induced inflammatory responses in mouse liver, with increased serum amyloid A proteins and Th17 cells","volume":"179","author":"Shi","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116309_b0250","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116309_b0255","first-page":"E208","article-title":"Prostaglandin F2alpha stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells","volume":"272","author":"Kozawa","year":"1997","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.bcp.2024.116309_b0260","doi-asserted-by":"crossref","first-page":"18930","DOI":"10.1074\/jbc.M209159200","article-title":"Incadronate amplifies prostaglandin F2 alpha-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity","volume":"278","author":"Tokuda","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:40:10Z","timestamp":1718854810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":52,"alternative-id":["S0006295224002922"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116309","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnane\u00a0X\u00a0receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F2\u03b1 (PGF2\u03b1) levels","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116309"}}